articles+ search results

878 articles+ results

1 - 20
View results as:
Number of results to display per page

1. Differential expression of interferon-induced genes and other tissue-based biomarkers in acute graft-versus-host disease vs. lupus erythematosus in skin [2019]

  • Lehman, J. S., Dasari, S., Damodaran, S. S., el-Azhary, R. A., Gibson, L. E., Hashmi, S. K., Hogan, W. J., Kenderian, S. J., Patnaik, M. S., Litzow, M. R., Lazarus, H. M., and Meves, A.
  • Clinical and Experimental Dermatology. June, 2019, Vol. 44 Issue 4, pe81, 8 p.

2. Infusion of autograft natural killer cell/CD14+HLA-DRDIM cell ratio predicts survival in lymphoma post autologous stem cell transplantation [2018]

  • Kansagra, A., Inwards, D. J., Ansell, S. M., Micallef, I. N., Johnston, P. B., Hogan, W. J., Markovic, S. N., and Porrata, L. F.
  • BONE MARROW TRANSPLANTATION -BASINGSTOKE THEN LONDON-. 53(2):146-154

3. Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation [2018]

  • Chakraborty, R., Muchtar, E., Kumar, S. K., Buadi, F. K., Dingli, D., Dispenzieri, A., Hayman, S. R., Hogan, W. J., Kapoor, P., and Lacy, M. Q.
  • BONE MARROW TRANSPLANTATION -BASINGSTOKE THEN LONDON-. 53(2):155-161

4. The impact of induction regimen on transplant outcome in newly diagnosed multiple myeloma in the era of novel agents [2017]

  • Chakraborty, R., Muchtar, E., Kumar, S., Buadi, F. K., Dingli, D., Dispenzieri, A., Hayman, S. R., Hogan, W. J., Kapoor, P., and Lacy, M. Q.
  • BONE MARROW TRANSPLANTATION -BASINGSTOKE THEN LONDON-. 52(1):34-40

5. A phase 1 trial of 90Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myeloma [2017]

  • Dispenzieri, A, Dʼsouza, A, Gertz, M A, Laumann, K, Wiseman, G, Lacy, M Q, LaPlant, B, Buadi, F, Hayman, S R, Kumar, S K, Dingli, D, Hogan, W J, Ansell, S M, Gastineau, D A, Inwards, D J, Micallef, I N, Porrata, L F, Johnston, P B, Litzow, M R, and Witzig, T E
  • Bone Marrow Transplantation. Oct 01, 2017 52(10):1372-1377

6. Autologous stem cell transplant for multiple myeloma patients 70 years or older [2016]

  • Muchtar, E., Dingli, D., Kumar, S., Buadi, F. K., Dispenzieri, A., Hayman, S. R., Wolf, R. C., Gastineau, D. A., Chakraborty, R., and Hogan, W. J.
  • BONE MARROW TRANSPLANTATION -BASINGSTOKE THEN LONDON-. 51(11):1449-1455

7. Azithromycin for the Treatment of Obliterative Bronchiolitis after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis [2016]

  • Yadav, H., Peters, S. G., Keogh, K. A., Hogan, W. J., Erwin, P. J., West, C. P., and Kennedy, C. C.
  • BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 22(12):2264-2269

8. Thrombotic Microangiopathy Care Pathway: A Consensus Statement for the Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy (CAP-TMA) Disease-Oriented Group [2016]

  • Go, R. S., Winters, J. L., Leung, N., Murray, D. L., Willrich, M. A., Abraham, R. S., Amer, H., Hogan, W. J., Marshall, A. L., and Sethi, S.
  • MAYO CLINIC PROCEEDINGS. 91(9):1189-1211

9. Employment Status as an Indicator of Recovery and Function One Year after Hematopoietic Stem Cell Transplantation [2016]

  • Morrison, E. J., Ehlers, S. L., Bronars, C. A., Patten, C. A., Brockman, T. A., Cerhan, J. R., Hogan, W. J., Hashmi, S. K., and Gastineau, D. A.
  • BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 22(9):1690-1695

10. Medical Students' Knowledge, Familiarity, and Attitudes towards Hematopoietic Stem Cell Donation [2016]

  • Narayanan, P., Wolanskyj, A., Ehlers, S. L., Litzow, M. R., Patnaik, M. S., Hogan, W. J., and Hashmi, S. K.
  • BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 22(9):1710-1716

11. Venous thromboembolism following hematopoietic stem cell transplantation—a systematic review and meta-analysis [2016]

  • Zahid, M. F., Murad, M. H., Litzow, M. R., Hogan, W. J., Patnaik, M. S., Khorana, A., Spyropoulos, A. C., and Hashmi, S. K.
  • ANNALS OF HEMATOLOGY. 95(9):1457-1464

12. In-vivo oesophageal regeneration in a human being by use of a non-biological scaffold and extracellular matrix [2016]

  • Dua, K. S., Hogan, W. J., Aadam, A. A., and Gasparri, M.
  • LANCET -LONDON-. 388(10039):55-61

13. The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review [2016]

  • Chaudhry, H. M., Bruce, A. J., Wolf, R. C., Litzow, M. R., Hogan, W. J., Patnaik, M. S., Kremers, W. K., Phillips, G. L., and Hashmi, S. K.
  • BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 22(4):605-616

14. Correlation of Pain and Fluoride Concentration in Allogeneic Hematopoietic Stem Cell Transplant Recipients on Voriconazole [2016]

  • Barajas, M. R., McCullough, K. B., Merten, J. A., Dierkhising, R. A., Bartoo, G. T., Hashmi, S. K., Hogan, W. J., Litzow, M. R., Patnaik, M. M., and Wilson, J. W.
  • BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 22(3):579-583

15. International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium [2016]

  • Harris, A. C., Young, R., Devine, S., Hogan, W. J., Ayuk, F., Bunworasate, U., Chanswangphuwana, C., Efebera, Y. A., Holler, E., and Litzow, M.
  • BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 22(1):4-10

16. Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT [2017]

  • DeFilipp, Z, Duarte, R F, Snowden, J A, Majhail, N S, Greenfield, D M, Miranda, J L, Arat, M, Baker, K S, Burns, L J, Duncan, C N, Gilleece, M, Hale, G A, Hamadani, M, Hamilton, B K, Hogan, W J, Hsu, J W, Inamoto, Y, Kamble, R T, Lupo-Stanghellini, M T, Malone, A K, McCarthy, P, Mohty, M, Norkin, M, Paplham, P, Ramanathan, M, Richart, J M, Salooja, N, Schouten, H C, Schoemans, H, Seber, A, Steinberg, A, Wirk, B M, Wood, W A, Battiwalla, M, Flowers, M ED, Savani, B N, and Shaw, B E
  • Bone Marrow Transplantation. Feb 01, 2017 52(2):173-182

17. 8.3 Laser drivers: KrF, solid state, 8.4 Fast ignition lasers for laser-driven IFE : 8 Inertial confinement fusion: laser [2005]

  • Heinloth, K., Editor, Hogan, W. J., and Martienssen, W., Editor-in-Chief
  • Nuclear Energy. 01/01/2005. 3B:461-479

18. 5 Controlled nuclear fusion: general aspects [2005]

  • Heinloth, K., Editor, Rebhan, E., Reiter, D., Weynants, R., Samm, U., Hogan, W. J., Raeder, J., Hamacher, T., and Martienssen, W., Editor-in-Chief
  • Nuclear Energy. 01/01/2005. 3B:304-368

19. 8.5 Reaction chamber and target positioning issues for laser IFE, 8.6 Final optics issues for laser IFE, 8.7 Development path for laser IFE : 8 Inertial confinement fusion: laser [2005]

  • Heinloth, K., Editor, Hogan, W. J., and Martienssen, W., Editor-in-Chief
  • Nuclear Energy. 01/01/2005. 3B:480-492

20. 8.1 Introduction, 8.2 Target types most suitable for laser drivers : 8 Inertial confinement fusion: laser [2005]

  • Heinloth, K., Editor, Hogan, W. J., and Martienssen, W., Editor-in-Chief
  • Nuclear Energy. 01/01/2005. 3B:453-460

Catalog

Books, media, physical & digital resources
See catalog results

Guides

Course- and topic-based guides to collections, tools, and services.
Search ""Hogan, W. J."" in all guide pages